1. Home
  2. CASH vs COLL Comparison

CASH vs COLL Comparison

Compare CASH & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$91.05

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$35.86

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASH
COLL
Founded
1954
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.2B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
CASH
COLL
Price
$91.05
$35.86
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$96.33
$50.83
AVG Volume (30 Days)
221.5K
419.5K
Earning Date
04-23-2026
01-01-0001
Dividend Yield
0.22%
N/A
EPS Growth
18.88
N/A
EPS
1.57
1.73
Revenue
$839,894,000.00
$780,567,000.00
Revenue This Year
$7.56
$6.07
Revenue Next Year
$6.02
N/A
P/E Ratio
$57.89
$20.65
Revenue Growth
11.29
23.62
52 Week Low
$64.45
$23.23
52 Week High
$96.06
$50.79

Technical Indicators

Market Signals
Indicator
CASH
COLL
Relative Strength Index (RSI) 53.76 26.84
Support Level $87.09 $34.30
Resistance Level $95.58 $36.20
Average True Range (ATR) 2.79 1.62
MACD -0.53 -0.39
Stochastic Oscillator 48.26 14.72

Price Performance

Historical Comparison
CASH
COLL

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: